Carrascosa, J.M.
Rivera, N.
Garcia-Doval, I.
Carretero, G.
Vanaclocha, F.
Daudén, E.
Gómez-García, F.J.
De-la-Cueva-Dobao, P.
Herrera-Ceballos, E.
Belinchón, I.
Alsina, M.
Sánchez-Carazo, J.L.
Ferrán, M.
Lopez-Estebaranz, J.L.
Pérez-Zafrilla, B.
Llamas, M.
Rivera, R.
Ferrándiz, C.
Funding for this research was provided by:
Fundación Academia Española de Dermatología y Venereología
Spanish Medicines and Health Products Agency
Abbott
PfizerMSD
Janssen
This article is maintained by: Elsevier
Article Title: Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time
Journal Title: Actas Dermo-Sifiliográficas (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.adengl.2015.04.019
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2015.04.013
Content Type: article
Copyright: Copyright © 2015 Elsevier España, S.L.U. and AEDV.